Granted Patent B2

US 12,421,519 · App. 17/421,278 · Granted Sep 23, 2025

Inventors: Douglas Higgins (Berkeley, CA); Andrew Abel Prior (Oakland, CA)

Assignee: Pivot Bio, Inc.

C12N15/74

Abstract

Claims (24)

1. An engineered bacterial cell, comprising:

(a) a native barcode polynucleotide cassette inserted into a genomic locus of the cell, the cassette having first, second and third native nucleotide sequences oriented 5′ to 3′; wherein,

(i) the first native nucleotide sequence serves as a forward primer binding site;

(ii) the second native nucleotide sequence serves as a barcode; and

(iii) the third native nucleotide sequence serves as a reverse primer binding site,

wherein the first, second and third native nucleotide sequences comprised within the native barcode polynucleotide cassette are from the same species as the engineered bacterial cell into which they are being inserted; and

wherein the genomic locus into which the native barcode polynucleotide cassette is inserted is at a heterologous location, as compared to the location in the genome of the first, second and third native nucleotide sequence.

2. The engineered bacterial cell of claim 1 , wherein the barcode is unique to different strains of the engineered bacterial cell.

3. The engineered bacterial cell of claim 1 , wherein the nucleotide sequence of at least one of the first, the second or the third native nucleotide sequence is isolated from ribosomal DNA or internal transcribed spacer (ITS) DNA.

4. The engineered bacterial cell of claim 1 , wherein the nucleotide sequence of at least one of the first, the second or the third native nucleotide sequence is 16S rDNA or 18S rDNA.

5. The engineered bacterial cell of claim 1 , wherein at least one of the primer binding sites is selected from 8F, 27F, CCF, 357F, 515F, 533F, 16S.1100.F16, 804F, 1237F, 338R, 519R, CDR, 806R, 907R, 1100R, 1391R, 1392R, 1492R(l), and 1492R(s).

6. The engineered bacterial cell of claim 1 , wherein the barcode comprises a constant barcode region and a variable barcode region.

7. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell is a non-intergeneric remodeled bacterial cell.

8. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell is capable of fixing atmospheric nitrogen in the presence of exogenous nitrogen.

9. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises at least one genetic variation introduced into at least one gene, or non-coding polynucleotide, of the nitrogen fixation or assimilation genetic regulatory network.

10. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises an introduced control sequence operably linked to at least one gene of the nitrogen fixation or assimilation genetic regulatory network.

11. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises a heterologous promoter operably linked to at least one gene of the nitrogen fixation or assimilation genetic regulatory network.

12. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises at least one genetic variation introduced into a member selected from the group consisting of: nifA, nifL, ntrB, ntrC, polynucleotide encoding glutamine synthetase, glnA, glnB, glnK, drat, amtB, polynucleotide encoding glutaminase, glnD, glnE, nifJ, nifH, nifD, nifK, nifY, nifE, nifN, nifU, nifS, nifV, nifW, nifZ, nifM, nifF, nifB, nifQ, a gene associated with biosynthesis of a nitrogenase enzyme, and combinations thereof.

13. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises at least one genetic variation introduced into at least one gene, or non-coding polynucleotide, of the nitrogen fixation or assimilation genetic regulatory network that results in one or more of increased expression or activity of NifA or glutaminase; decreased expression or activity of NifL, NtrB, glutamine synthetase, GlnB, GlnK, DraT, AmtB; decreased adenylyl-removing activity of GlnE; and decreased uridylyl-removing activity of GlnD.

14. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell comprises at least one of: a mutated nifL gene comprising a heterologous promoter in said nifL gene; a mutated glnE gene that results in a truncated GlnE protein lacking an adenylyl-removing (AR) domain; a mutated amtB gene that results in the lack of expression of said amtB gene; and combinations thereof.

15. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell is selected from Rahnella aquatilis, Klebsiella variicola, Achromobacter spiritimus, Achromobacter marplatensis, Microbacterium murale, Kluyvera intermedia, Kosakonia pseudosacchari, Enterobacter sp., Azospirillum lipoferun , and Kosakonia sacchari.

16. The engineered bacterial cell of claim 1 , wherein the engineered bacterial cell is endophytic, epiphytic, or rhizospheric.

17. The engineered bacterial cell of claim 1 , wherein the genomic locus into which the native barcode polynucleotide cassette is inserted between two coding regions separated by a terminator region.

18. The engineered bacterial cell of claim 1 , wherein the genomic locus into which the native barcode polynucleotide cassette is inserted at a set distance from an origin of replication.

Assignments (2)

Continuity (3)

References Cited (262)

Cited By (4)

US 12,610,956 US 12,643,837 US 12,692,203 US 12,735,713